One page, thousands of outlets. See who else covered it.
(MedPage Today) -- The FDA approved garetosmab (Pasatru) to reduce the formation of new heterotopic ossification lesions and disease flares in adults with fibrodysplasia ossificans progressiva (FOP), the agency announced on Wednesday. A monoclonal...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Doctors will walk off the job today across several major hospitals in Melbourne.
Doctors will walk off the job today across several major hospitals in Melbourne.
The combined drug works by nudging the body’s own immune system to make proteins that attack and destroy melanoma cells
St. Jude CEO Dr. Charles W. M. Roberts said he believes this is a "once-in-a-lifetime opportunity" to achieve the dream of treating cancer in children.
